CONSEGNA 30X70 U 200 PENFIL 3 ML

How CONSEGNA 30X70 U 200 PENFIL 3 ML Works

• CONSEGNA 30X70 U 200 PENFIL 3 ML contains insulin, a vital hormone naturally produced by the pancreas. In individuals with diabetes, the pancreas either doesn't produce enough insulin (Type 1 diabetes) or the body becomes resistant to the insulin that is produced (Type 2 diabetes). CONSEGNA acts as a replacement for or supplement to the body's own insulin, enabling glucose (sugar) to move from the bloodstream into cells where it can be used for energy.
• The insulin in CONSEGNA is specifically designed to be a rapid-acting insulin. This means that it starts working very quickly after injection, typically within 10-20 minutes. It reaches its peak effect in about 1-3 hours and its effects last for approximately 3-5 hours. This rapid action profile makes it particularly useful for managing blood sugar levels around mealtimes. By taking CONSEGNA shortly before or after eating, individuals can better control the rise in blood glucose that occurs after consuming food.
• CONSEGNA 30X70 is a premixed insulin containing 30% rapid-acting insulin and 70% intermediate-acting insulin. The rapid-acting component helps to cover the glucose surge after meals, while the intermediate-acting component provides a longer-lasting background insulin coverage, helping to control blood glucose levels between meals and overnight. This combination provides a more convenient way to manage blood sugar levels with fewer injections compared to using separate rapid and intermediate-acting insulins.
• When injected subcutaneously (under the skin), CONSEGNA is absorbed into the bloodstream. The insulin molecules then bind to insulin receptors on the surface of cells throughout the body. This binding triggers a cascade of intracellular events that ultimately leads to the translocation of glucose transporters (GLUT4) to the cell membrane. These transporters facilitate the uptake of glucose from the bloodstream into the cells, thereby lowering blood glucose levels.
• By facilitating the uptake of glucose into cells, CONSEGNA helps to normalize blood sugar levels. This is crucial for preventing both short-term and long-term complications of diabetes. Short-term complications of high blood sugar include frequent urination, excessive thirst, unexplained weight loss, blurred vision, and increased susceptibility to infections. Long-term complications can include damage to the nerves (neuropathy), kidneys (nephropathy), eyes (retinopathy), and cardiovascular system.
• It is important to use CONSEGNA exactly as prescribed by your healthcare provider. The dosage and timing of injections will depend on individual factors such as your blood sugar levels, diet, and activity level. Regular monitoring of blood glucose levels is essential to ensure that CONSEGNA is effectively controlling your diabetes. Your healthcare provider will also advise you on how to adjust your dosage as needed based on your blood sugar readings.

Like all medicines, CONSEGNA 30X70 U 200 PENFIL 3 ML can cause side effects, although not everybody gets them. **Common Side Effects (may affect up to 1 in 10 people):** * Hypoglycemia (low blood sugar): Symptoms may include sweating, shaking, anxiety, blurred vision, rapid heartbeat, dizziness, hunger, and confusion. Severe hypoglycemia can lead to unconsciousness and, in very rare cases, can be fatal. It's crucial to treat hypoglycemia immediately. * Injection site reactions: Redness, pain, itching, swelling, or bruising at the injection site. * Lipodystrophy: Changes in fat tissue at the injection site (either thickening or pitting of the skin). * Weight gain * Edema (swelling), particularly in the ankles and feet **Uncommon Side Effects (may affect up to 1 in 100 people):** * Allergic reactions: Rash, itching, hives. * Severe allergic reactions (anaphylaxis): Although rare, seek immediate medical attention if you experience difficulty breathing, wheezing, swelling of the face, tongue, or throat, rapid heartbeat, or dizziness. * Peripheral neuropathy (nerve damage): Symptoms may include pain, numbness, or tingling in the hands or feet. * Diabetic retinopathy (eye disease): Worsening of existing diabetic retinopathy. **Rare Side Effects (may affect up to 1 in 1,000 people):** * Muscle pain **Very Rare Side Effects (may affect up to 1 in 10,000 people):** * None Reported **Other Possible Side Effects (frequency not known):** * Sodium Retention **Important Considerations:** * This is not an exhaustive list. Tell your doctor if you experience any unusual symptoms while taking CONSEGNA. * Certain medical conditions or medications can increase the risk of side effects. Discuss your medical history and all medications you are taking with your doctor. * The frequency and severity of side effects can vary from person to person.

• If you miss a dose of CONSEGNA 30X70 U 200 PENFIL 3 ML, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed dose.
• Contact your doctor if you are not sure what to do.

• Keep CONSEGNA 30X70 U 200 PENFIL 3ML away from the reach of children and pets.
• Store CONSEGNA 30X70 U 200 PENFIL 3ML in a refrigerator (2 - 8°C). Do not freeze.

• **Understand Your Dosage:** CONSEGNA 30X70 U 200 PENFIL 3 ML contains a specific concentration of insulin (U-200). Ensure you understand your prescribed dosage and how to dial it correctly on the pen. Incorrect dosage can lead to hypo- or hyperglycemia. Always double-check the units before injecting.
• **Proper Injection Technique:** Rotate injection sites within the recommended areas (abdomen, thigh, or upper arm) to prevent lipohypertrophy (lumps under the skin). Inject at a 90-degree angle (or 45 degrees if using a shorter needle and thinner skin). Pinch the skin to create a fold before injecting, especially if you have less subcutaneous fat.
• **Priming the Pen:** Before each injection, prime the CONSEGNA pen by dialing 2 units and injecting into the air. Repeat until a drop of insulin appears. This ensures the pen is working correctly and delivers an accurate dose. This is crucial for consistent results.
• **Storage is Key:** Store unopened CONSEGNA pens in the refrigerator (2°C to 8°C or 36°F to 46°F). Once in use, the pen can be stored at room temperature (below 30°C or 86°F) for up to 28 days. Avoid direct sunlight and heat. Discard the pen after 28 days, even if it still contains insulin.
• **Monitor Blood Glucose Regularly:** Consistently monitor your blood glucose levels as directed by your healthcare provider. This helps you understand how CONSEGNA is affecting your blood sugar and allows for dosage adjustments as needed. Keep a log of your readings to share with your doctor.
• **Recognize Hypoglycemia Symptoms:** Be aware of the symptoms of hypoglycemia (low blood sugar), such as shakiness, sweating, dizziness, and confusion. Carry a source of fast-acting glucose (glucose tablets, juice) with you at all times and treat hypoglycemia immediately. Inform family and friends how to help you if you experience severe hypoglycemia.
• **Travel Smart:** When traveling with CONSEGNA, carry it in your hand luggage with a copy of your prescription. Keep insulin away from extreme temperatures. If crossing time zones, consult your doctor about adjusting your insulin schedule.
• **Check Insulin Appearance:** Before each injection, visually inspect the insulin in the CONSEGNA pen. It should be clear and colorless. Do not use it if it appears cloudy, discolored, or contains particles.
• **Needle Safety:** Use a new needle for each injection to ensure sterility and prevent infection. Dispose of used needles properly in a sharps container. Never share needles or pens with others.
• **Consult Your Doctor Regularly:** Schedule regular check-ups with your doctor to review your diabetes management plan, including your CONSEGNA dosage and injection technique. Discuss any concerns or side effects you are experiencing.

• There are no known food interactions with CONSEGNA 30X70 U 200 PENFIL 3 ML. You can take CONSEGNA 30X70 U 200 PENFIL 3 ML without regard to meals. However, maintaining a consistent dietary pattern is important for overall diabetes management.